Not Signed In -
Propranolol Injection |
Inderal IV |
Clinical Trial: Propranolol for Treatment of Cocaine Addiction - 2
This study is no longer recruiting patients.
Purpose
The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: Propranolol | Phase II |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Propranolol for Treatment of Cocaine Addiction
Further Study Details:
Study start: January 1987
Eligibility
Ages Eligible for Study: 25 Years - 49 Years, Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania, 19104 6178, United States
Study chairs or principal investigators
Kyle Kampman, M.D., Principal Investigator, University of Pennsylvania
More Information
Study ID Numbers: NIDA-00238-2; K02-00238-2
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000197
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000197
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Inderal IV (Drug Digest)
- Propranolol Injection (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
